Laura L Lechner, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7 Community Dr, Buffalo, NY 14225 Phone: 716-505-5630 Fax: 716-892-1936 |
Mrs. Bethany B Hauer, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Buffalo Hearing And Speech, 50 East North St, Buffalo, NY 14203 Phone: 716-885-8318 Fax: 716-885-0229 |
Mrs. Deborah Ann Fitzgerald, OT/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2495 Main St, Suite 234, Buffalo, NY 14214 Phone: 716-836-5929 |
Cheryl Kagen Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2495 Main St, Suite 234, Buffalo, NY 14214 Phone: 716-836-5929 |
Ms. Andrea Cudney, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 301 Connecticut St Ste 202, Buffalo, NY 14213 Phone: 716-923-4617 |
Miss Lisa Anne Dagustine, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2495 Main St, Buffalo, NY 14214 Phone: 716-836-5929 |
Michelle Moulin, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2495 Main St, Suite 234, Buffalo, NY 14214 Phone: 716-836-5929 |
Dustin Alan Brown, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 2900 Delaware Ave, Buffalo, NY 14217 Phone: 716-871-9915 |
James Joseph Marshall, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3495 Bailey Ave, Buffalo, NY 14215 Phone: 716-862-7437 |
Ms. Jennifer L Bartelo, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2495 Main St, Suite 234, Buffalo, NY 14214 Phone: 716-836-5929 |
Kenita Theresa Williams, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2980 William St, Buffalo, NY 14227 Phone: 716-892-2062 |
Mrs. Maria T Mclaughlin, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 462 Grider St, Buffalo, NY 14215 Phone: 716-898-5040 Fax: 716-898-3259 |
Laura Armenia Fumerelle Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2253 Main St, Buffalo, NY 14214 Phone: 716-834-7200 |
Ms. Randi Bergman Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 33 Ash St, School 12 Related Services, Buffalo, NY 14204 Phone: 716-816-4748 |
Courtney Patridge, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 50 E North St, Buffalo, NY 14203 Phone: 716-885-8318 Fax: 716-885-0229 |
Mrs. Kimberly Anne Bennett, O.T.R. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2495 Main St, Buffalo, NY 14214 Phone: 716-836-5929 Fax: 716-836-6057 |
Carley Miller, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2495 Main St, Buffalo, NY 14214 Phone: 716-862-0641 |
Christine L Budzynski, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 666 E Delavan Ave, Buffalo, NY 14215 Phone: 716-816-4494 |
Mrs. Caitlin Anne Romeo, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 40 Days Park, Buffalo, NY 14201 Phone: 716-886-4581 |
Mr. David Andrew Vokes, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 219 Bryant St, Buffalo, NY 14222 Phone: 716-878-7470 Fax: 716-878-1157 |
News Archive
OsteoSymbionics, innovative designer and manufacturer of patient-specific craniofacial implants, is pleased to announce FDA (U.S. Food and Drug Administration) 510(k) clearance for sterile processing of its signature ClearShield™ cranial implant product, utilizing a novel room temperature peracetic acid/hydrogen peroxide (PAA) vacuum vapor sterilization process.
Fitch Ratings sees an active year for new drug applications to be registered to U.S. and European drug regulators considering recent updates to the pharmaceutical industry's late-stage R&D programs. According to Fitch's new Global Pharmaceutical R&D Pipeline report, the Fitch-rated pharmaceutical developers listed in the report plan on submitting marketing applications to the U.S. Food & Drug Administration (FDA) or the European Medicines Agency (EMEA) during 2010 for approval of 22 novel drug therapies.
Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for KRX-0401 (perifosine), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits the phosphoinositide 3-kinase (PI3K)/Akt pathway, for the treatment of relapsed/refractory multiple myeloma.
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite's skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream.
› Verified 1 days ago